<b>Supplementary figure 2. </b>IGFBP-3 (a.) and ALS (b.) versus IGF-I+II measured by<b> </b>LC-MS/MS in healthy subjects.
<p dir="ltr">A subgroup of blood samples from healthy children and adolescents (59% girls) enrolled in the ongoing cross-sectional, population-based Copenhagen Puberty Study III (COPUS III) was analyzed of bioactive IGF-I (KIRA) and quantified by IGF-I, -II (n=440), IGFBP-3 (n=362) a...
Salvato in:
| Autore principale: | |
|---|---|
| Pubblicazione: |
2025
|
| Soggetti: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|